Tom H. Johnston received his BSc in pharmacology from the University of Manchester and a PhD from King’s College London. Dr. Johnston is currently the chief operating officer of Atuka Inc., a preclinical contract research organization with facilities in Canada and China. His research focuses primarily on the pharmacology of Parkinson’s disease (PD). Dr. Johnston has considerable experience in modeling preclinical PD and in developing and translating novel therapies, work that has been described in more than 65 peer-reviewed publications.